183 related articles for article (PubMed ID: 19350684)
21. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist.
Broxmeyer HE; Orschell CM; Clapp DW; Hangoc G; Cooper S; Plett PA; Liles WC; Li X; Graham-Evans B; Campbell TB; Calandra G; Bridger G; Dale DC; Srour EF
J Exp Med; 2005 Apr; 201(8):1307-18. PubMed ID: 15837815
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic targeting and rapid mobilization of endosteal HSC using a small molecule integrin antagonist.
Cao B; Zhang Z; Grassinger J; Williams B; Heazlewood CK; Churches QI; James SA; Li S; Papayannopoulou T; Nilsson SK
Nat Commun; 2016 Mar; 7():11007. PubMed ID: 26975966
[TBL] [Abstract][Full Text] [Related]
23. A novel CXCR4 antagonist for hematopoietic stem cell mobilization.
Fricker SP
Expert Opin Investig Drugs; 2008 Nov; 17(11):1749-60. PubMed ID: 18922110
[TBL] [Abstract][Full Text] [Related]
24. The current status in hematopoietic stem cell mobilization.
Civriz Bozdag S; Tekgunduz E; Altuntas F
J Clin Apher; 2015 Oct; 30(5):273-80. PubMed ID: 25790158
[TBL] [Abstract][Full Text] [Related]
25. CXC-chemokine receptor 4 antagonist AMD3100 promotes cardiac functional recovery after ischemia/reperfusion injury via endothelial nitric oxide synthase-dependent mechanism.
Jujo K; Ii M; Sekiguchi H; Klyachko E; Misener S; Tanaka T; Tongers J; Roncalli J; Renault MA; Thorne T; Ito A; Clarke T; Kamide C; Tsurumi Y; Hagiwara N; Qin G; Asahi M; Losordo DW
Circulation; 2013 Jan; 127(1):63-73. PubMed ID: 23204107
[TBL] [Abstract][Full Text] [Related]
26. Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100.
Nervi B; Ramirez P; Rettig MP; Uy GL; Holt MS; Ritchey JK; Prior JL; Piwnica-Worms D; Bridger G; Ley TJ; DiPersio JF
Blood; 2009 Jun; 113(24):6206-14. PubMed ID: 19050309
[TBL] [Abstract][Full Text] [Related]
27. Enhanced unique pattern of hematopoietic cell mobilization induced by the CXCR4 antagonist 4F-benzoyl-TN14003.
Abraham M; Biyder K; Begin M; Wald H; Weiss ID; Galun E; Nagler A; Peled A
Stem Cells; 2007 Sep; 25(9):2158-66. PubMed ID: 17525235
[TBL] [Abstract][Full Text] [Related]
28. AMD3100 and CD26 modulate mobilization, engraftment, and survival of hematopoietic stem and progenitor cells mediated by the SDF-1/CXCL12-CXCR4 axis.
Broxmeyer HE; Hangoc G; Cooper S; Campbell T; Ito S; Mantel C
Ann N Y Acad Sci; 2007 Jun; 1106():1-19. PubMed ID: 17360804
[TBL] [Abstract][Full Text] [Related]
29. In and out of the niche: perspectives in mobilization of hematopoietic stem cells.
Mohty M; Ho AD
Exp Hematol; 2011 Jul; 39(7):723-9. PubMed ID: 21624427
[TBL] [Abstract][Full Text] [Related]
30. Rational identification of a Cdc42 inhibitor presents a new regimen for long-term hematopoietic stem cell mobilization.
Liu W; Du W; Shang X; Wang L; Evelyn C; Florian MC; A Ryan M; Rayes A; Zhao X; Setchell K; Meller J; Guo F; Nassar N; Geiger H; Pang Q; Zheng Y
Leukemia; 2019 Mar; 33(3):749-761. PubMed ID: 30254339
[TBL] [Abstract][Full Text] [Related]
31. Mobilization as a preparative regimen for hematopoietic stem cell transplantation.
Chen J; Larochelle A; Fricker S; Bridger G; Dunbar CE; Abkowitz JL
Blood; 2006 May; 107(9):3764-71. PubMed ID: 16439683
[TBL] [Abstract][Full Text] [Related]
32. New agents for mobilizing peripheral blood stem cells.
Greinix HT; Worel N
Transfus Apher Sci; 2009 Aug; 41(1):67-71. PubMed ID: 19615944
[TBL] [Abstract][Full Text] [Related]
33. CXCR4 Antagonist AMD3100 Promotes Mesenchymal Stem Cell Mobilization in Rats Preconditioned with the Hypoxia-Mimicking Agent Cobalt Chloride.
Liu L; Yu Q; Fu S; Wang B; Hu K; Wang L; Hu Y; Xu Y; Yu X; Huang H
Stem Cells Dev; 2018 Apr; 27(7):466-478. PubMed ID: 29433375
[TBL] [Abstract][Full Text] [Related]
34. The CXCR4 agonist peptide, CTCE-0021, rapidly mobilizes polymorphonuclear neutrophils and hematopoietic progenitor cells into peripheral blood and synergizes with granulocyte colony-stimulating factor.
Pelus LM; Bian H; Fukuda S; Wong D; Merzouk A; Salari H
Exp Hematol; 2005 Mar; 33(3):295-307. PubMed ID: 15730853
[TBL] [Abstract][Full Text] [Related]
35. The role of G-protein signaling in hematopoietic stem/progenitor cell mobilization.
Papayannopoulou T; Priestley GV; Bonig H; Nakamoto B
Blood; 2003 Jun; 101(12):4739-47. PubMed ID: 12595315
[TBL] [Abstract][Full Text] [Related]
36. Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist.
Liles WC; Broxmeyer HE; Rodger E; Wood B; Hübel K; Cooper S; Hangoc G; Bridger GJ; Henson GW; Calandra G; Dale DC
Blood; 2003 Oct; 102(8):2728-30. PubMed ID: 12855591
[TBL] [Abstract][Full Text] [Related]
37. Continuous blockade of CXCR4 results in dramatic mobilization and expansion of hematopoietic stem and progenitor cells.
Karpova D; Ritchey JK; Holt MS; Abou-Ezzi G; Monlish D; Batoon L; Millard S; Spohn G; Wiercinska E; Chendamarai E; Yang W; Christ S; Gehrs L; Schuettpelz LG; Dembowsky K; Pettit AR; Rettig MP; Bonig H; DiPersio JF
Blood; 2017 May; 129(21):2939-2949. PubMed ID: 28400375
[TBL] [Abstract][Full Text] [Related]
38. Parathyroid hormone is a DPP-IV inhibitor and increases SDF-1-driven homing of CXCR4(+) stem cells into the ischaemic heart.
Huber BC; Brunner S; Segeth A; Nathan P; Fischer R; Zaruba MM; Vallaster M; Theiss HD; David R; Gerbitz A; Franz WM
Cardiovasc Res; 2011 Jun; 90(3):529-37. PubMed ID: 21245057
[TBL] [Abstract][Full Text] [Related]
39. Dual stem cell therapy after myocardial infarction acts specifically by enhanced homing via the SDF-1/CXCR4 axis.
Theiss HD; Vallaster M; Rischpler C; Krieg L; Zaruba MM; Brunner S; Vanchev Y; Fischer R; Gröbner M; Huber B; Wollenweber T; Assmann G; Mueller-Hoecker J; Hacker M; Franz WM
Stem Cell Res; 2011 Nov; 7(3):244-55. PubMed ID: 21752744
[TBL] [Abstract][Full Text] [Related]
40. Novel insight into stem cell mobilization-plasma sphingosine-1-phosphate is a major chemoattractant that directs the egress of hematopoietic stem progenitor cells from the bone marrow and its level in peripheral blood increases during mobilization due to activation of complement cascade/membrane attack complex.
Ratajczak MZ; Lee H; Wysoczynski M; Wan W; Marlicz W; Laughlin MJ; Kucia M; Janowska-Wieczorek A; Ratajczak J
Leukemia; 2010 May; 24(5):976-85. PubMed ID: 20357827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]